These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32307937)

  • 1. Comparison of the Efficacy of Tibolone and Transdermal Estrogen in Treating Menopausal Symptoms in Postmenopausal Women.
    Kim HK; Jeon SH; Ryu KJ; Kim T; Park H
    J Menopausal Med; 2019 Dec; 25(3):123-129. PubMed ID: 32307937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.
    Prelevic GM; Bartram C; Wood J; Okolo S; Ginsburg J
    Gynecol Endocrinol; 1996 Dec; 10(6):413-20. PubMed ID: 9032569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of tibolone and transdermal estrogen therapy on psychological symptoms in women following surgical menopause.
    Baksu A; Ayas B; Citak S; Kalan A; Baksu B; Goker N
    Int J Gynaecol Obstet; 2005 Oct; 91(1):58-62. PubMed ID: 15970290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of tibolone and transdermal estradiol on triglyceride level in hypertriglyceridemic and normotriglyceridemic postmenopausal women.
    Dansuk R; Unal O; Karageyim Y; Esim E; Turan C
    Gynecol Endocrinol; 2004 May; 18(5):233-9. PubMed ID: 15346658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short and long term effects of tibolone in postmenopausal women.
    Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transdermal estradiol gel and oral tibolone on health-related quality of life after surgical menopause.
    Bhattacharya SM; Jha A
    Int J Gynaecol Obstet; 2010 Sep; 110(3):213-6. PubMed ID: 20570264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Tibolone in Relieving Postmenopausal Symptoms for a Short-Term Period in Indian Women.
    Malik R; Meghana Reddy P
    J Obstet Gynaecol India; 2023 Jun; 73(3):242-247. PubMed ID: 36532125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    Fedele L; Bianchi S; Raffaelli R; Zanconato G
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tibolone on sexual function in late postmenopausal women.
    Kamenov ZA; Todorova MK; Christov VG
    Folia Med (Plovdiv); 2007; 49(1-2):41-8. PubMed ID: 18018469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the effects of continuous hormone replacement therapy and tibolone on the genital tract of menopausal women; a randomized controlled trial.
    Saeideh Z; Raziyeh M; Soghrat F
    J Reprod Infertil; 2010 Oct; 11(3):183-7. PubMed ID: 23926488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of menopausal symptoms using modified Menopause Rating Scale (MRS) among middle age women in Kuching, Sarawak, Malaysia.
    Rahman SA; Zainudin SR; Mun VL
    Asia Pac Fam Med; 2010 Feb; 9(1):5. PubMed ID: 20175928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.
    Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG
    Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
    Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
    Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
    Hammar M; Christau S; Nathorst-Böös J; Rud T; Garre K
    Br J Obstet Gynaecol; 1998 Aug; 105(8):904-11. PubMed ID: 9746385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
    Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
    Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.